Declan Soden

Dr. Declan Soden

Scienist

Background

Declan has worked in the area of targeted gene and drug delivery to tumours for the last decade. In that time his group has initiated 3 novel Phase I clinical trials, and currently over 350 patients have received a novel form of therapy for inoperable skin cancers. They have developed a device for the electroporation/permeabilisation of gastrointestinal tract cancers which facilitates a significant improvement in local drug or DNA absorption without the normally associated systemic side effects.

-Patented medical devices for the minimally invasive electroporation assisted ablation of internal cancers
-Awarded Irish Medicines Board approval to commence a Phase I trial using a new endoscopic system to treat colorectal cancer (November 2009) and lung cancer (April 2011).
-Awarded Innovation of the Year award for 2011 based on Lung cancer work.

 

Sponsor